Fineline Cube

Follow:
14486 Articles
AstraZeneca's Imfinzi Approved in EU for Limited-Stage Small Cell Lung Cancer
CompanyDrug

AstraZeneca’s Imfinzi Approved in EU for Limited-Stage Small Cell Lung Cancer

HutchMed and Innovent Announce Positive Results for Fruquintinib and Sintilimab in Renal Cell Carcinoma Trial
CompanyDrug

HutchMed and Innovent Announce Positive Results for Fruquintinib and Sintilimab in Renal Cell Carcinoma Trial

Convalife and XLement Launch AI-Powered Joint Lab for Drug Development Innovation
CompanyDeals

Convalife and XLement Launch AI-Powered Joint Lab for Drug Development Innovation

Celregen Therapeutics Secures RMB100 Million for iPSC Regenerative Medicine Platform
Company

Celregen Therapeutics Secures RMB100 Million for iPSC Regenerative Medicine Platform

GE Healthcare Launches AltiX AI.i Edition for Enhanced Cardiac Procedures
CompanyMedical Device

GE Healthcare Launches AltiX AI.i Edition for Enhanced Cardiac Procedures

WuXi AppTec Reports Steady Revenue Growth Amid Diversified Business Expansion
Company

WuXi AppTec Reports Steady Revenue Growth Amid Diversified Business Expansion

Eisai Launches JPY16 Billion Tender for EcoNaviSta to Expand Dementia Care Ecosystem
CompanyDeals

Eisai Launches JPY16 Billion Tender for EcoNaviSta to Expand Dementia Care Ecosystem

Bayer's Kerendia Gets FDA Priority Review for Heart Failure with Preserved Ejection Fraction
CompanyDrug

Bayer’s Kerendia Gets FDA Priority Review for Heart Failure with Preserved Ejection Fraction

HMZS Biopharmaceutical Blacklisted After Failing to Monitor Production Process
Policy / Regulatory

HMZS Biopharmaceutical Blacklisted After Failing to Monitor Production Process

IceCure Medical Secures Chinese Patent for Cryogenic System Connector
CompanyMedical Device

IceCure Medical Secures Chinese Patent for Cryogenic System Connector

FibroGen Reports Decline in Sales, Pushes Ahead with Roxadustat and New Drug Development
Company

FibroGen Reports Decline in Sales, Pushes Ahead with Roxadustat and New Drug Development

Taiho Pharmaceutical to Acquire Araris Biotech for USD 400 Million, Expanding ADC Portfolio
CompanyDeals

Taiho Pharmaceutical to Acquire Araris Biotech for USD 400 Million, Expanding ADC Portfolio